omega-n-methylarginine has been researched along with ag-213 in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (ag-213) | Trials (ag-213) | Recent Studies (post-2010) (ag-213) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 224 | 0 | 4 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | ag-213 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 3.222 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 5.7 | |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 3.0667 | |
| Protein kinase C alpha type | Homo sapiens (human) | 3 | |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | 3 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 3 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 3 | |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | 3 | |
| Receptor protein-tyrosine kinase | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chik, CL; Ho, AK; Murdoch, G; Ogiwara, T | 1 |
1 other study(ies) available for omega-n-methylarginine and ag-213
| Article | Year |
|---|---|
Tyrosine kinase inhibitors enhance cGMP production in rat pinealocytes.
Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Oxidoreductases; Animals; Arginine; Catechols; Cyclic AMP; Cyclic GMP; Genistein; Hydroquinones; Isoflavones; Isoproterenol; Male; Nitric Oxide Synthase; Nitriles; Norepinephrine; omega-N-Methylarginine; Pineal Gland; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tyrphostins | 1995 |